DHA / DOH / MOH exam (UAE) gastroenterology questions

Classic heartburn and regurgitation worsened by meals and recumbency, without alarm features, is diagnostic of gastroesophageal reflux disease (GERD) on clinical grounds alone, and formal investigation is not required before starting treatment. GERD results from transient lower esophageal sphincter relaxation allowing acid reflux into the esophagus. Guidelines recommend an empirical approach in young patients with typical symptoms and no red flags.

• A. Acute coronary syndrome would present with exertional or acute chest pain, not a chronic pattern tied to meals and posture, and vital signs are normal here.
• B. Motility disorders such as achalasia classically cause dysphagia to solids and liquids, which this patient does not have.
• D. Peptic ulcer disease typically causes epigastric pain related to eating, not primarily postural, meal-triggered burning with regurgitation.

In patients under 50 years with typical reflux symptoms and no alarm features, international guidelines recommend an empirical trial of a once-daily proton pump inhibitor for 4-8 weeks as first-line management. Symptom improvement supports the diagnosis and avoids unnecessary invasive testing. Lifestyle measures (weight loss, avoiding late meals, elevating the head of the bed) are advised alongside therapy.

• A. pH monitoring is used for atypical symptoms or when the diagnosis is uncertain despite a PPI trial, not as initial management.
• B. Endoscopy is reserved for patients with alarm features, poor response to empirical therapy, or those over the age threshold for screening.
• C. H. pylori testing is relevant for dyspepsia with suspected ulcer disease, not for typical uncomplicated reflux symptoms.

Dysphagia, unintentional weight loss, and anemia in a patient over 55 years with reflux symptoms are alarm features that mandate prompt upper gastrointestinal endoscopy to exclude esophageal or gastric malignancy and other structural disease. Delaying investigation with an empirical drug trial risks missing a treatable cancer at an early stage. Endoscopy also allows biopsy of any suspicious lesion.

• A. Barium swallow may show a stricture or mass but does not allow biopsy and is not the preferred first investigation when malignancy is suspected.
• C. An empirical PPI trial is appropriate only in the absence of alarm features; here it would delay diagnosis of a potentially serious cause.
• D. Reassurance is inappropriate given the alarm features of dysphagia, weight loss, and anemia, which require prompt investigation.

Patients with long-standing (typically more than 5-10 years) chronic GERD, especially men over 50 with additional risk factors such as obesity or a family history, should undergo upper gastrointestinal endoscopy with biopsy to screen for Barrett's esophagus. Biopsy confirms the presence and grade of intestinal metaplasia, which guides surveillance intervals and detects dysplasia early. Endoscopy also allows direct visualization of the columnar-lined segment that defines Barrett's esophagus.

• B. Barium swallow can suggest a hiatal hernia or stricture but cannot provide histologic confirmation of intestinal metaplasia.
• C. Serum gastrin is used to evaluate suspected gastrinoma (Zollinger-Ellison syndrome), not to screen for Barrett's esophagus.
• D. Manometry assesses esophageal motor function and is used to evaluate dysphagia or suspected motility disorders, not to screen for Barrett's esophagus.

Recurrent food impaction and intermittent solid food dysphagia in a young adult with an atopic background, along with endoscopic findings of concentric rings (trachealization) and longitudinal furrows, are characteristic of eosinophilic esophagitis. Diagnosis is confirmed by esophageal biopsy showing more than 15 eosinophils per high-power field. Management includes dietary elimination, topical (swallowed) corticosteroids, and proton pump inhibitors as first-line options.

• A. Peptic strictures occur in older patients with long-standing reflux and typically show a smooth, fibrotic narrowing rather than rings and furrows.
• B. Esophageal carcinoma usually presents in older patients with progressive dysphagia and weight loss, not recurrent impactions over years in a young adult.
• C. Achalasia causes dysphagia to both liquids and solids due to impaired lower esophageal sphincter relaxation, not the ringed mucosal appearance described.

The bird-beak sign on barium swallow, a dilated esophagus tapering smoothly to a narrow lower esophageal sphincter with delayed emptying, is the classic radiographic finding of achalasia. This occurs due to loss of inhibitory neurons in the myenteric plexus, causing failure of lower esophageal sphincter relaxation and absent peristalsis. Esophageal manometry confirming elevated integrated relaxation pressure and absent peristalsis is used to establish the diagnosis definitively.

• B. A peptic stricture usually appears as a short, smooth narrowing in the distal esophagus associated with chronic reflux, without the proximal dilation typical of achalasia.
• C. Adenocarcinoma typically produces an irregular, shouldered stricture with mucosal destruction rather than a smooth symmetric taper.
• D. Diffuse esophageal spasm classically shows a "corkscrew" appearance on barium swallow due to simultaneous uncoordinated contractions, not a smooth tapering narrowing.

Progressive dysphagia (solids before liquids), significant weight loss, and odynophagia in an older patient with long-standing smoking and alcohol use are classic for esophageal carcinoma, particularly squamous cell carcinoma in this risk profile. The progressive nature of the dysphagia, moving from solids to liquids, reflects mechanical luminal narrowing by a growing tumor. Urgent endoscopy with biopsy is required to confirm the diagnosis and stage the disease.

• B. Esophageal candidiasis usually occurs in immunocompromised patients and presents with odynophagia rather than a progressive mechanical dysphagia pattern with major weight loss.
• C. Diffuse esophageal spasm causes intermittent chest pain and dysphagia to both liquids and solids, not a progressive pattern with marked weight loss.
• D. Achalasia typically causes dysphagia to both solids and liquids from the outset rather than a progressive solid-to-liquid pattern, and is not linked to smoking and alcohol.

A Mallory-Weiss tear results from a sudden, forceful increase in intra-abdominal and intragastric pressure during retching or vomiting, causing a longitudinal mucosal and submucosal laceration at the gastroesophageal junction. This typically follows a bout of forceful vomiting, often in the setting of alcohol use, and presents with hematemesis after an initial episode of non-bloody vomiting. Most cases are self-limited and managed supportively, as the tear does not involve the full esophageal wall.

• A. Chronic acid-related mucosal erosion describes reflux esophagitis, which develops gradually and is not triggered by a single episode of forceful vomiting.
• B. Variceal bleeding results from portal hypertension in patients with chronic liver disease, not from an acute retching episode in an otherwise healthy young man.
• C. Transmural perforation describes Boerhaave syndrome, which causes severe chest pain and mediastinitis, a more severe and distinct entity from a mucosal tear.

Boerhaave syndrome is a transmural esophageal perforation caused by a sudden rise in intraesophageal pressure during forceful vomiting, classically following a large meal or alcohol binge. The triad of vomiting, severe chest pain, and subcutaneous emphysema (Mackler's triad) is highly suggestive, and the crunching sound on auscultation (Hamman's sign) reflects mediastinal air. Prompt recognition is critical because mediastinitis and sepsis develop rapidly, and mortality rises steeply with delayed diagnosis and surgical repair beyond 24 hours. Contrast esophagography or CT with oral contrast confirms the diagnosis.

• A. Pneumothorax can cause chest pain and tachypnea but does not typically follow vomiting or produce a mediastinal crunching sound.
• B. Myocardial infarction does not explain subcutaneous crepitus or a vomiting-triggered onset with Hamman's sign.
• D. A Mallory-Weiss tear causes a mucosal (not transmural) tear presenting with hematemesis, not subcutaneous emphysema or mediastinal crunch.

The urea breath test is a noninvasive, highly sensitive and specific method that detects active H. pylori infection by measuring labeled CO2 released from bacterial urease activity, and it is the preferred test for confirming eradication 4 weeks after completing therapy. Serum antibody testing cannot distinguish active from past infection because antibodies persist after clearance. Biopsy-based tests (rapid urease, histology) require endoscopy, which is unnecessary in a young patient without alarm features. Both urea breath test and stool antigen test require stopping PPIs for 2 weeks and antibiotics/bismuth for 4 weeks before testing for accuracy.

• A. Rapid urease testing requires endoscopic biopsy, an invasive step not indicated in this low-risk patient.
• B. Histology also requires endoscopic biopsy and is reserved for patients undergoing endoscopy for other indications.
• C. Serum IgG antibodies remain positive long after successful eradication, making this test unsuitable for confirming cure.

Standard triple therapy with a proton pump inhibitor plus amoxicillin and clarithromycin for 14 days remains first-line in regions with low clarithromycin resistance (under 15%), as recommended by current guidelines including the Maastricht VI/Florence consensus. The PPI suppresses acid to promote antibiotic efficacy and ulcer healing, while the two antibiotics act synergistically to eradicate the organism. Fourteen-day courses have replaced older 7-10 day regimens because they achieve higher eradication rates. Bismuth-based quadruple therapy is reserved for penicillin allergy, prior macrolide exposure, or known/suspected clarithromycin resistance.

• B. Bismuth quadruple therapy is reserved for penicillin allergy or clarithromycin resistance, not first-line in a low-resistance setting.
• C. Dual therapy without a second antibiotic has unacceptably low eradication rates and is not recommended.
• D. Omitting amoxicillin reduces eradication efficacy; triple therapy requires two antibiotics plus a PPI.

Co-prescribing a proton pump inhibitor is the most effective and guideline-recommended strategy for reducing NSAID-associated peptic ulcer risk, particularly in patients with additional risk factors such as concurrent antiplatelet therapy, older age, or cardiovascular disease. PPIs significantly reduce both gastric and duodenal ulcer incidence by suppressing acid-mediated mucosal injury and are superior to standard-dose H2 blockers for this indication. Enteric coating reduces local gastric irritation but does not prevent systemic prostaglandin-mediated mucosal injury, so it does not eliminate ulcer risk. Sucralfate has not demonstrated reliable protective efficacy against NSAID-induced ulcers and is not recommended for this purpose.

• A. Sucralfate lacks proven efficacy for preventing NSAID-induced ulcers and is not a recommended prophylactic agent.
• B. Standard-dose H2 blockers are less effective than PPIs at preventing NSAID-induced ulcers, especially in high-risk patients.
• D. Enteric coating reduces direct gastric irritation but does not prevent systemic COX-mediated mucosal injury, so ulcer risk persists.

Pneumoperitoneum with peritonitis in the setting of known peptic ulcer disease indicates a perforated ulcer, a surgical emergency requiring immediate intravenous fluid resuscitation, broad-spectrum antibiotics to cover peritoneal contamination, and urgent surgical consultation for exploratory laparotomy or laparoscopic repair. Endoscopy is contraindicated in suspected perforation because insufflation can worsen leakage of gastrointestinal contents into the peritoneal cavity. Nasogastric decompression may be used as an adjunct but does not substitute for surgical management and fluid resuscitation. Delaying definitive surgical intervention increases mortality from ongoing peritoneal contamination and sepsis.

• B. Outpatient management is inappropriate for a surgical emergency with peritonitis and free air.
• C. Endoscopy is contraindicated in suspected perforation because insufflated air can worsen peritoneal contamination.
• D. Nasogastric decompression alone is insufficient; the patient needs resuscitation, antibiotics, and surgery.

Recurrent, multiple, or unusually distal peptic ulcers refractory to standard therapy, especially with accompanying diarrhea that improves with acid suppression, raise suspicion for Zollinger-Ellison syndrome caused by a gastrin-secreting tumor (gastrinoma). A fasting serum gastrin level is the appropriate initial test, as markedly elevated levels (especially with gastric pH below 2) support the diagnosis and warrant further evaluation with secretin stimulation testing and tumor localization imaging. Diarrhea in this syndrome results from the massive acid load overwhelming pancreatic enzyme function and damaging the small bowel mucosa. Amylase, lipase, and stool studies do not address the underlying hypergastrinemic state driving ulcer recurrence.

• A. Amylase and lipase assess pancreatitis and would not explain recurrent refractory ulcers with secretory diarrhea.
• B. Stool culture evaluates infectious diarrhea, which does not explain this patient's recurrent ulcer pattern.
• D. Gallstones cause biliary colic, not recurrent peptic ulceration or acid-responsive diarrhea.

The Glasgow-Blatchford score uses hemoglobin, blood urea nitrogen, systolic blood pressure, heart rate, and clinical features (melena, syncope, hepatic disease, cardiac failure) to predict need for intervention in upper GI bleeding. A score of 0 identifies patients at very low risk of rebleeding, transfusion, or death, who can be safely discharged for outpatient endoscopic evaluation rather than admitted. This patient has normal hemoglobin, normal urea, stable vitals, and no high-risk comorbidities, giving him a score of 0. Using this score correctly avoids unnecessary hospitalization while preserving safety.

• B. His parameters (normal hemoglobin, urea, stable vitals) give a score of 0, not a high score.
• C. There is no hemodynamic instability requiring intensive care or vasopressors.
• D. Surgery is not indicated as a first step in a hemodynamically stable patient with a low-risk bleed.

In patients with acute upper GI bleeding presenting with hemodynamic instability (hypotension, tachycardia) despite initial fluid resuscitation, current guidelines recommend urgent endoscopy within 12 hours after adequate hemodynamic resuscitation has begun. This allows timely identification and endoscopic control of the bleeding source, such as a bleeding ulcer or varix, reducing rebleeding and mortality. Resuscitation with intravenous fluids and blood products should proceed in parallel, not delay, early endoscopy in unstable patients. Stable, low-risk patients can have endoscopy within 24 hours instead.

• A. Oral iron and observation do not address an active, hemodynamically significant bleed.
• B. Outpatient endoscopy is unsafe in a patient who is actively bleeding and hemodynamically unstable.
• D. A 24-hour window is appropriate for stable patients, not for ongoing hemodynamic instability.

In suspected variceal hemorrhage, a vasoactive drug such as terlipressin (or alternatively octreotide or somatostatin) should be started as soon as possible to reduce splanchnic blood flow and portal pressure, ideally before endoscopy. Short-term antibiotic prophylaxis, typically with a third-generation cephalosporin, is also recommended in all cirrhotic patients with GI bleeding because it reduces the risk of bacterial infection and improves survival. Proton pump inhibitors alone do not address the underlying portal hypertension driving variceal bleeding. This combination forms the cornerstone of pharmacologic management while awaiting definitive endoscopic therapy such as band ligation.

• B. Tranexamic acid is not recommended in GI bleeding and propranolol is for long-term secondary prophylaxis, not acute bleeding.
• C. PPIs are used for peptic ulcer bleeding, not as primary therapy for variceal hemorrhage.
• D. Vitamin K does not acutely reverse coagulopathy fast enough and is not the standard combination for variceal bleeding.

Rome IV criteria define irritable bowel syndrome as recurrent abdominal pain at least one day per week in the last three months, associated with two or more of: relation to defecation, change in stool frequency, or change in stool form, with symptom onset at least six months prior. This patient's pain is linked to defecation and altered stool pattern, with no alarm features such as weight loss, bleeding, nocturnal symptoms, or abnormal inflammatory markers. In the absence of red flags, extensive investigation is not required, and a positive clinical diagnosis of IBS can be made. Alarm symptoms would warrant further workup, such as colonoscopy, to exclude organic disease.

• A. Colorectal carcinoma is unlikely at this age without alarm features such as bleeding, weight loss, or family history.
• B. Celiac disease usually involves malabsorption features or weight loss, and would be suggested by specific serology, not present in this scenario.
• D. Crohn disease typically presents with additional features such as weight loss, elevated inflammatory markers, or extraintestinal manifestations, which are absent here.

In IBS with constipation (IBS-C), first-line pharmacologic management includes osmotic laxatives such as polyethylene glycol to improve stool frequency and consistency. In IBS with diarrhea (IBS-D), first-line management includes loperamide, an antidiarrheal that reduces stool frequency and urgency without affecting underlying motility disorder severity. Lifestyle and dietary measures, such as fiber adjustment and low-FODMAP diet, are complementary to pharmacologic treatment in both subtypes. Antispasmodics may also be used for pain in either subtype, but the laxative and antidiarrheal choices are subtype-specific first-line agents.

• A. SSRIs are considered in refractory cases with comorbid psychological symptoms, not as first-line therapy for either subtype.
• B. Antibiotics and corticosteroids are not standard first-line therapy for either IBS subtype.
• C. This reverses the appropriate first-line agents for each subtype.

Uncomplicated acute diverticulitis in a hemodynamically stable patient who can tolerate oral intake, without evidence of abscess, perforation, or sepsis, can be managed as an outpatient with oral antibiotics covering gram-negative and anaerobic organisms, such as ciprofloxacin plus metronidazole, or amoxicillin-clavulanate. A clear liquid diet is advanced as tolerated, with symptomatic improvement generally expected within 2-3 days. Surgery is reserved for complicated or recurrent disease, not first episodes of uncomplicated diverticulitis. Hospitalization is reserved for patients with significant comorbidities, inability to tolerate oral intake, or signs of systemic illness.

• A. Vancomycin targets gram-positive organisms and intensive care is not indicated for this stable presentation.
• C. Current guidelines favor antibiotics in this presentation with CT-confirmed inflammation, not antibiotic omission for all cases presenting with imaging findings and systemic inflammatory response.
• D. Surgery is reserved for complicated diverticulitis, not an uncomplicated first episode.

Features such as a palpable tender mass, high fever, marked leukocytosis, tachycardia, and signs suggestive of obstruction raise concern for complicated diverticulitis, including abscess formation, perforation, or fistula. Contrast-enhanced CT of the abdomen and pelvis is the investigation of choice to confirm the diagnosis, characterize the extent of disease, and identify abscesses that may require percutaneous drainage or surgical intervention. Colonoscopy is contraindicated in the acute phase due to risk of perforation and should be deferred for 6 weeks after resolution to exclude malignancy. Barium enema carries similar risks acutely and is not first-line in this setting.

• A. This presentation indicates likely complicated disease requiring admission and imaging, not outpatient discharge.
• B. Barium enema is not used in the acute setting due to perforation risk and has been largely replaced by CT imaging.
• D. Colonoscopy during acute diverticulitis risks perforation and is deferred until inflammation resolves.

Diverticular bleeding is the most common cause of acute lower GI bleeding in older adults and classically presents as sudden, painless, large-volume hematochezia, often with a known history of diverticulosis. Bleeding arises from erosion of a penetrating artery at the neck or dome of a diverticulum. It is usually self-limited but can recur, as in this patient. Angiodysplasia tends to cause more occult or intermittent bleeding and is more strongly associated with chronic kidney disease and aortic stenosis.

• A. Ischemic colitis usually presents with crampy abdominal pain and bloody diarrhea, not painless massive hematochezia.
• B. Hemorrhoidal bleeding is typically bright red, coats the stool, and is associated with defecation, not large-volume maroon stools.
• D. Angiodysplasia more often causes occult or slow venous-type bleeding rather than sudden large-volume hematochezia.

Anal fissure presents with severe, tearing pain during and persisting after defecation, often described as passing glass, with small amounts of bright red bleeding. The classic location is the posterior midline, and a visible linear mucosal tear on gentle separation of the buttocks confirms the diagnosis clinically. Hard stool from chronic constipation is the typical precipitant. Hemorrhoids are usually painless unless thrombosed or prolapsed, which helps distinguish them from fissures.

• B. Perianal abscess presents with constant throbbing pain, fever, and a fluctuant swelling, not a linear tear with pain tied to defecation.
• C. External hemorrhoids cause pain mainly when thrombosed, presenting as a tender perianal lump rather than a linear tear.
• D. Internal hemorrhoids are typically painless and present with painless bleeding or prolapse, not severe post-defecation pain.

After an adequate trial of lifestyle and dietary fiber modification fails, osmotic laxatives such as polyethylene glycol are the recommended first-line pharmacologic step in chronic constipation, as they are effective, well-tolerated, and have a strong evidence base for long-term use. Bulk-forming agents are typically tried alongside or before further escalation but have already been addressed through increased fiber intake here. Stimulant laxatives and secretagogues are reserved for cases that fail osmotic laxative therapy.

• A. Secretagogues like lubiprostone are reserved for refractory constipation unresponsive to osmotic and stimulant laxatives.
• B. Stimulant laxatives are generally reserved as second-line therapy after osmotic laxatives fail.
• D. Bulk-forming laxative benefit has essentially already been attempted through increased dietary fiber intake.

Most cases of acute infectious diarrhea are self-limited and viral or mild bacterial in origin, and the mainstay of treatment is oral rehydration therapy with electrolyte solution to correct and prevent dehydration. Antibiotics are not routinely indicated for mild, non-bloody diarrhea without high fever, systemic toxicity, or risk factors such as immunosuppression. Empiric antibiotics are reserved for dysentery, suspected cholera, severe traveler's diarrhea, or immunocompromised patients. This patient has mild symptoms, no fever, and no blood in stool, so supportive care alone is appropriate.

• B. Empiric antibiotics are not indicated for mild, non-bloody, afebrile diarrhea without signs of invasive or severe infection.
• C. Metronidazole is used for suspected giardiasis or amoebiasis, not for this acute mild watery diarrhea presentation.
• D. Azithromycin is reserved for proven or strongly suspected bacterial dysentery or severe traveler's diarrhea, not mild self-limited illness.

Ulcerative colitis characteristically causes continuous, circumferential mucosal inflammation beginning in the rectum and extending proximally without skip lesions, with histology confined to the mucosa and submucosa showing crypt abscesses but no granulomas. Bloody diarrhea with mucus and tenesmus is the classic presentation. Crohn's disease, in contrast, typically shows skip lesions, transmural inflammation, and may feature granulomas and perianal disease, none of which are present here. The continuous rectal-based distribution and superficial histology point specifically to ulcerative colitis.

• A. Crohn's disease typically shows skip lesions, transmural inflammation, and granulomas, which are absent here.
• C. Infectious colitis is usually acute and self-limited, and biopsy would not typically show this chronic pattern of continuous mucosal disease with crypt abscesses.
• D. Ischemic colitis typically affects watershed areas like the splenic flexure segmentally, not with continuous rectal-based involvement, and usually occurs in older patients with vascular risk factors.

Fecal calprotectin is a sensitive marker of intestinal mucosal inflammation and is recommended as the initial test to distinguish inflammatory bowel disease from irritable bowel syndrome in patients with lower GI symptoms without alarm features. A normal fecal calprotectin has a high negative predictive value for excluding active IBD, helping avoid unnecessary colonoscopy in low-risk patients, while an elevated level warrants further endoscopic evaluation. It is non-invasive, inexpensive, and well validated for this purpose in current guidelines.

• B. Stool ova and parasite testing evaluates for parasitic infection, not for distinguishing inflammatory from functional bowel disease.
• C. Abdominal ultrasound lacks the sensitivity to reliably detect mucosal inflammation and is not the recommended first-line discriminating test.
• D. CA 19-9 is a tumor marker used in suspected pancreatic or biliary malignancy, not for differentiating IBD from IBS.

Mild-to-moderate ulcerative colitis, especially when limited to the distal colon, is treated first-line with 5-aminosalicylates (mesalamine), given orally, rectally, or both, which reduce mucosal inflammation and induce remission in most patients. Oral corticosteroids are reserved for patients who fail to respond to mesalamine or who have moderate-severe disease. Intravenous steroids are used for severe or fulminant colitis requiring hospitalization. Biologics such as infliximab are reserved for steroid-refractory or moderate-severe disease.

• A. Used for severe or fulminant colitis requiring hospitalization, not mild disease.
• C. Biologic therapy is reserved for moderate-severe or refractory disease, not first-line mild colitis.
• D. Reserved for moderate-severe disease or mesalamine failure, not first-line for mild disease.

Toxic megacolon is a life-threatening complication of ulcerative colitis (and occasionally Crohn colitis or infectious colitis) characterized by colonic dilation greater than 6 cm on plain radiograph together with systemic toxicity, including fever above 38°C, tachycardia, hypotension, or altered mental status. It results from transmural inflammation that paralyzes colonic smooth muscle, risking perforation. Management requires urgent resuscitation, bowel rest, intravenous corticosteroids, broad-spectrum antibiotics, and early surgical consultation, since colectomy may be needed if there is no improvement within 24-72 hours.

• A. Ischemic colitis typically occurs in older patients with vascular risk factors and does not explain this degree of colonic dilation with known UC.
• B. Pancreatitis presents with epigastric pain radiating to the back and elevated amylase/lipase, not colonic dilation with a bloody diarrhea history.
• C. A perforated ulcer causes sudden severe epigastric pain with free air on imaging, not progressive colonic distension in a UC patient.

Patients with extensive ulcerative colitis have an increased risk of colorectal cancer that rises with disease duration, prompting surveillance colonoscopy with systematic or targeted biopsies beginning 8-10 years after symptom onset. After the initial screening examination, repeat colonoscopy is generally recommended every 1-3 years depending on individual risk factors such as extent of disease, degree of inflammation, and family history. Patients with concomitant primary sclerosing cholangitis require annual surveillance starting at diagnosis. Relying on symptoms or fecal occult blood testing alone is inadequate because dysplasia and early cancer are often asymptomatic.

• B. A 10-year interval is used for average-risk general population screening, not for long-standing extensive colitis.
• C. Surveillance is indicated regardless of symptoms because dysplasia is often clinically silent.
• D. Fecal occult blood testing has poor sensitivity for dysplasia and does not replace colonoscopic surveillance in IBD.

IgA anti-tissue transglutaminase (tTG-IgA) antibody is the recommended first-line serologic test for celiac disease because of its high sensitivity and specificity in patients with normal total IgA levels. A positive result should be followed by upper endoscopy with duodenal biopsies showing villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis to confirm the diagnosis, and testing must be performed while the patient remains on a gluten-containing diet to avoid false negatives. Total serum IgA should be checked alongside tTG-IgA to exclude IgA deficiency, which would necessitate IgG-based testing instead.

• B. ANA is relevant to autoimmune connective tissue disease, not celiac disease.
• C. Stool microscopy evaluates for parasitic infection, not an autoimmune enteropathy.
• D. Barium studies may show nonspecific small bowel changes but are not used for celiac diagnosis.

The cornerstone of celiac disease management is a strict, lifelong gluten-free diet, which allows mucosal healing and resolution of symptoms and malabsorption. Adherence is monitored clinically and by tracking tTG-IgA titers, which should decline and normalize over 6-12 months with good dietary compliance; persistently elevated titers suggest ongoing gluten exposure. Dietitian referral and patient education are essential, as even small amounts of gluten can perpetuate mucosal damage. Corticosteroids, antibiotics, and acid suppression have no role in routine management of uncomplicated celiac disease.

• A. Corticosteroids are not standard therapy for celiac disease and do not address the underlying gluten-driven immune response.
• B. Acid suppression is irrelevant to celiac disease, and gluten restriction must be continuous rather than intermittent.
• C. Celiac disease is not an infectious process, so antibiotics have no role, and gluten must be avoided permanently, not temporarily.

The hydrogen breath test after an oral lactose load is the standard confirmatory test for lactose intolerance, demonstrating a rise in breath hydrogen due to colonic bacterial fermentation of unabsorbed lactose. Lactose intolerance typically presents with symptoms temporally related to dairy intake and resolves with lactose avoidance, without systemic features such as weight loss or anemia seen in malabsorptive disorders like celiac disease. A negative tTG-IgA makes celiac disease unlikely, so further celiac-specific antibody testing or duodenal biopsy is unnecessary. Colonoscopy is not indicated since the symptoms and distribution point to a small bowel carbohydrate malabsorption process rather than colonic pathology.

• A. Colonoscopy evaluates colonic mucosa and is not the test used to diagnose a carbohydrate malabsorption syndrome.
• B. Duodenal biopsy is used to confirm celiac disease, which is already made unlikely by negative serology and the clinical pattern here.
• D. Anti-endomysial antibody is another celiac-specific test, unnecessary when the picture already points to lactose intolerance.

Plain abdominal radiographs in supine and erect (or decubitus) positions are the initial imaging investigation of choice for suspected small bowel obstruction, typically showing dilated small bowel loops greater than 3 cm with air-fluid levels arranged in a stepladder pattern, and absent or reduced colonic gas. Adhesions from prior abdominal or pelvic surgery, as in this patient with a history of hysterectomy, are the most common cause of small bowel obstruction. If plain films are inconclusive or further detail on the site and cause is needed, contrast-enhanced CT of the abdomen is the next step. Ultrasound and barium enema have limited roles in the initial assessment of suspected mechanical small bowel obstruction.

• A. MRI is not first-line due to cost and availability; plain radiography is the appropriate initial test.
• C. Barium enema evaluates colonic pathology and is contraindicated in suspected obstruction due to perforation risk.
• D. Ultrasound is not the standard initial test for suspected mechanical small bowel obstruction in adults.

The acute onset of marked transaminase elevation, jaundice, and dark urine following likely fecal-oral exposure (street food) is classic for acute hepatitis A. IgM anti-HAV appears early in acute infection and confirms current or recent disease, while IgG anti-HAV indicates past infection or immunity. Hepatitis A is typically self-limited, requiring only supportive care, and patients should be counseled on strict hand hygiene and avoiding alcohol and hepatotoxic drugs during recovery. Fulminant hepatic failure is rare but more common in older adults or those with underlying liver disease.

• A. IgG anti-HAV reflects past infection or vaccination, not acute illness.
• B. There is no risk factor or serology suggesting hepatitis B, and the exposure history favors a fecal-oral route.
• D. Hepatitis C is usually acquired parenterally and rarely causes such an acute symptomatic presentation.

Isolated anti-HBs positivity with negative HBsAg and negative anti-HBc indicates immunity from vaccination rather than natural infection. In natural infection, anti-HBc (core antibody) is produced and persists for life, whereas vaccination induces antibody only against the surface antigen (anti-HBs). This distinction is clinically important for differentiating vaccine-induced immunity from past infection. The patient's vaccination history and negative anti-HBc support this interpretation.

• B. Acute infection requires a positive HBsAg and/or IgM anti-HBc, both negative in this patient.
• C. Resolved natural infection would show a positive anti-HBc (total) in addition to anti-HBs.
• D. Chronic infection requires a positive HBsAg persisting beyond 6 months, which is absent here.

A positive hepatitis C antibody test indicates past or present exposure but does not distinguish active infection from spontaneously cleared or treated disease. HCV RNA by PCR is the confirmatory test that detects active viremia and is required before considering antiviral treatment. Genotyping is useful for guiding treatment regimen selection but is only performed after confirming active infection with detectable RNA. Liver biopsy is not required for diagnosis in the current direct-acting antiviral era.

• A. Repeating the antibody test does not distinguish active from resolved infection and delays diagnosis unnecessarily.
• B. Genotyping guides treatment choice but is performed only after confirming active viremia with RNA testing.
• C. Liver biopsy is not needed to confirm active HCV infection and is reserved for specific staging indications.

Lifestyle modification with gradual weight loss (7–10% of body weight) through dietary change and increased physical activity is the cornerstone of first-line management for non-alcoholic fatty liver disease, improving steatosis and reducing fibrosis risk. Pioglitazone and vitamin E are reserved for patients with biopsy-proven non-alcoholic steatohepatitis who do not respond to lifestyle measures, and pioglitazone carries risks such as weight gain and fluid retention. Statins may be used if dyslipidemia coexists but do not treat the underlying fatty liver disease itself. Addressing obesity and insulin resistance targets the primary driver of NAFLD.

• B. Vitamin E is reserved for non-diabetic patients with biopsy-proven steatohepatitis, not first-line therapy for simple steatosis.
• C. Pioglitazone is a second-line option used mainly in biopsy-confirmed steatohepatitis, not initial management.
• D. Statins do not treat the underlying fatty liver disease and are not the primary intervention.

Maddrey's discriminant function, calculated from prothrombin time and serum bilirubin, is the classic scoring system used to assess severity in alcoholic hepatitis and determine whether corticosteroid therapy is indicated; a score of 32 or higher indicates severe disease with significant short-term mortality risk and is the threshold for considering steroids. The elevated bilirubin and prolonged prothrombin time in this patient reflect severe hepatic dysfunction consistent with severe alcoholic hepatitis. While MELD score is also used in some centers and correlates with mortality, Maddrey's discriminant function remains the historically validated and most widely referenced tool specifically for this treatment decision. Child-Pugh score and FIB-4 are used for general cirrhosis severity and fibrosis staging rather than guiding steroid therapy in acute alcoholic hepatitis.

• A. FIB-4 index estimates hepatic fibrosis stage and is not used for acute severity assessment in alcoholic hepatitis.
• B. MELD score is an alternative prognostic tool but is not the classic criterion used to decide on corticosteroid therapy in this condition.
• D. Child-Pugh score assesses general cirrhosis severity and prognosis, not the specific decision to start steroids in alcoholic hepatitis.

The combination of spironolactone (an aldosterone antagonist) and furosemide (a loop diuretic) is the recommended first-line pharmacologic therapy for cirrhotic ascites, addressing the secondary hyperaldosteronism that drives sodium and water retention in cirrhosis. Starting both agents together in a standard ratio (commonly 100:40 mg) from the outset allows more rapid natriuresis while minimizing the risk of hyperkalemia or hypokalemia compared to sequential dosing. Sodium restriction is also an essential adjunct to diuretic therapy. Spironolactone alone is used for mild ascites, while furosemide alone is generally avoided as monotherapy due to risk of hypokalemia and insufficient natriuretic response.

• A. Amiloride alone is a less potent potassium-sparing option and not the standard first-line choice compared to the spironolactone-furosemide combination.
• C. Furosemide alone is not preferred as initial therapy because it does not counteract the hyperaldosteronism driving fluid retention and risks hypokalemia.
• D. Hydrochlorothiazide is not an effective or standard diuretic for cirrhotic ascites.

An ascitic fluid absolute neutrophil (polymorphonuclear leukocyte) count greater than 250 cells/mm³ is the diagnostic criterion for spontaneous bacterial peritonitis, regardless of ascitic fluid culture results, and should prompt immediate empirical antibiotic therapy. A total white cell count threshold is less specific because it includes lymphocytes and monocytes, diluting the diagnostic value of neutrophil predominance seen in bacterial infection. The serum-ascites albumin gradient helps classify the cause of ascites as portal hypertensive or not, but does not diagnose infection. Ascitic protein level helps assess the risk of SBP and differentiate transudate from exudate but is not itself diagnostic.

• B. A serum-ascites albumin gradient greater than 11 g/L indicates portal hypertension as the cause of ascites, not infection.
• C. Total white cell count is less specific than the neutrophil count for diagnosing infection in ascitic fluid.
• D. Ascitic protein level reflects fluid characteristics and SBP risk but is not the diagnostic criterion for active infection.

This patient's hepatic encephalopathy has been precipitated by constipation, a common trigger that increases ammonia absorption from the gut. Oral lactulose is the first-line treatment, acting as a non-absorbable disaccharide that acidifies the colon, promotes ammonia trapping as ammonium, and induces catharsis to reduce nitrogenous load. Rifaximin is typically added for secondary prophylaxis or in patients who do not respond adequately to lactulose alone, not as initial monotherapy. Identifying and correcting the precipitant, in this case constipation, is essential alongside lactulose therapy.

• B. Intravenous mannitol is used for cerebral edema in acute liver failure, not for hepatic encephalopathy in chronic cirrhosis.
• C. Intravenous ceftriaxone would be appropriate if there were signs of infection such as spontaneous bacterial peritonitis, which are absent here.
• D. Rifaximin is used as an adjunct to lactulose, typically for recurrent encephalopathy, not as first-line monotherapy.

Acute cholecystitis is suggested by pain lasting longer than 6 hours, fever, tachycardia, leukocytosis, and a positive Murphy sign (inspiratory arrest on palpation of the right upper quadrant due to gallbladder inflammation). It results from cystic duct obstruction, usually by a gallstone, leading to gallbladder wall inflammation and often secondary bacterial infection. Biliary colic, by contrast, causes self-limited pain typically lasting under 6 hours without fever or leukocytosis, since there is no inflammation. Acute pancreatitis presents with epigastric pain radiating to the back and elevated lipase, and choledocholithiasis typically causes jaundice and cholestatic liver enzymes from common bile duct obstruction, neither of which is described here.

• A. Biliary colic causes transient pain without fever, tachycardia, or leukocytosis, unlike this prolonged, inflammatory presentation.
• B. Choledocholithiasis typically presents with jaundice and cholestatic liver enzyme elevation from bile duct obstruction, not described here.
• C. Acute pancreatitis presents with epigastric pain radiating to the back and elevated serum lipase, not a positive Murphy sign.

Transabdominal ultrasound is the first-line imaging investigation for suspected gallstone disease because it is non-invasive, widely available, inexpensive, and has high sensitivity and specificity for detecting gallstones and assessing gallbladder wall thickness or pericholecystic fluid. CT is less sensitive for gallstones, since many are isoechoic to bile on CT, and exposes the patient to radiation. MRCP is reserved for evaluating suspected choledocholithiasis or biliary ductal abnormalities when ultrasound findings are inconclusive. A HIDA scan is used to assess gallbladder function or confirm acute cholecystitis when ultrasound is equivocal, not as a first-line test.

• A. HIDA scan assesses gallbladder function and is used as a second-line test, not first-line imaging.
• B. CT is less sensitive for detecting gallstones than ultrasound and involves radiation exposure.
• C. MRCP is reserved for further evaluation of the bile ducts when ultrasound findings are inconclusive, not as the initial test.

The revised Atlanta classification states that acute pancreatitis is diagnosed when at least two of three criteria are present: characteristic abdominal pain, serum lipase or amylase elevated at least three times the upper limit of normal, and characteristic findings on imaging. This patient already fulfills two criteria (typical pain and lipase more than three times normal), so imaging is not mandatory for diagnosis, although it is useful here to identify gallstones as the cause. CT is reserved for diagnostic uncertainty or suspected complications, not for confirming straightforward cases. Amylase has lower sensitivity and specificity than lipase and a normal level does not exclude pancreatitis.

• A. The Atlanta criteria require only two of the three features, not all three.
• B. CT is not required in every case; it is reserved for diagnostic doubt or suspected complications, and is usually delayed to 72 hours if performed.
• C. Amylase is less sensitive and specific than lipase and can be normal in confirmed pancreatitis, especially with delayed presentation or alcoholic etiology.

A pancreatic pseudocyst is a well-defined, encapsulated fluid collection lacking significant solid debris that typically develops more than 4 weeks after an episode of acute pancreatitis, consistent with this patient's timeline and imaging. It arises from disruption of the pancreatic duct with leakage of pancreatic fluid that becomes walled off by fibrous or granulation tissue rather than a true epithelial lining. Small asymptomatic pseudocysts are managed conservatively, while symptomatic or enlarging ones may require endoscopic, percutaneous, or surgical drainage. Walled-off necrosis, in contrast, contains solid necrotic debris and also develops after about 4 weeks, but imaging here explicitly shows no solid component.

• A. An abscess would typically present with fever, systemic toxicity, and gas or debris within the collection, none of which are present here.
• B. Adenocarcinoma presents as a solid, infiltrative mass, often with ductal dilation or vascular invasion, not a thin-walled fluid collection following pancreatitis.
• C. Walled-off necrosis contains heterogeneous solid necrotic material within the collection, which is absent on this CT.

This patient has chronic pancreatitis with exocrine pancreatic insufficiency, confirmed by steatorrhea, weight loss, and low fecal elastase, resulting from progressive loss of acinar cell mass and reduced secretion of lipase and other digestive enzymes. First-line treatment is oral pancreatic enzyme replacement therapy, taken with meals and snacks, which improves fat digestion and absorption and reduces steatorrhea-related symptoms. Enzyme preparations are enteric-coated to prevent gastric acid degradation, and a proton pump inhibitor may be added as an adjunct to improve enzyme efficacy by reducing acid-mediated enzyme inactivation, but it is not the primary treatment. Nutritional supplementation with fat-soluble vitamins and dietary modification may also be needed, but enzyme replacement remains central.

• A. Total parenteral nutrition is not first-line for exocrine insufficiency and is reserved for patients unable to tolerate enteral intake.
• C. A PPI alone does not replace the missing digestive enzymes and only serves as an adjunct to enhance enzyme activity.
• D. There is no indication of bacterial overgrowth here; the clinical and laboratory picture is explained by enzyme deficiency, not bacterial overgrowth.

Painless progressive jaundice with weight loss and a palpable, non-tender distended gallbladder (Courvoisier's sign) is a classic red-flag presentation for malignant obstruction of the distal common bile duct, most commonly from a pancreatic head adenocarcinoma. These findings warrant urgent referral for contrast-enhanced CT of the abdomen and pancreas to characterize a pancreatic mass, assess resectability, and guide further management such as endoscopic ultrasound with biopsy or ERCP for biliary drainage. Delaying evaluation risks progression of an already time-sensitive malignancy. There is no fever, pain, or leukocytosis to suggest cholangitis, and ursodeoxycholic acid has no role in malignant biliary obstruction.

• A. Ursodeoxycholic acid is used for conditions like primary biliary cholangitis or gallstone dissolution, not malignant biliary obstruction.
• B. Reassurance and delay are inappropriate given red-flag features strongly suggestive of underlying malignancy requiring urgent evaluation.
• C. There is no fever or signs of infection to support cholangitis; antibiotics would not address the underlying obstructive mass.

Unexplained iron-deficiency anemia in a man over 50 years, or in a postmenopausal woman, is a red-flag indication for colonoscopy to exclude colorectal cancer or other colonic pathology, even in the absence of overt gastrointestinal bleeding or weight loss. Since upper endoscopy has already excluded a proximal source, the colon must be evaluated next because it is the most likely remaining site of occult blood loss in this age group. Starting iron empirically without investigating the cause risks missing an underlying malignancy. Capsule endoscopy and CT are reserved for cases where both upper and lower endoscopy are negative and small bowel pathology is suspected.

• A. Capsule endoscopy evaluates the small bowel and is used only after colonoscopy and upper endoscopy are both negative.
• B. CT is not the first-line investigation for evaluating unexplained iron-deficiency anemia; colonoscopy is more sensitive for mucosal lesions.
• D. Empirical iron therapy without investigating the cause risks delaying diagnosis of an underlying colorectal malignancy.

H. pylori infection causes chronic active inflammation of the gastric mucosa, leading to progressive glandular atrophy and intestinal metaplasia, a sequence known as the Correa cascade. Intestinal metaplasia is a precancerous change that can progress through dysplasia to invasive adenocarcinoma, particularly the intestinal-type gastric cancer. This stepwise mechanism explains why eradication of H. pylori before the development of atrophic changes reduces gastric cancer risk. The World Health Organization classifies H. pylori as a class I carcinogen based on this inflammatory pathway.

• A. H. pylori is an extracellular bacterium and does not integrate its DNA into host cells; it promotes carcinogenesis through chronic inflammation and virulence factors like CagA, not direct genomic integration.
• C. Gastric cancer arising from H. pylori-related atrophic gastritis develops through local mucosal change, not a circulating toxin causing distant metastasis without primary tumor formation.
• D. Bile reflux is not the accepted mechanism linking H. pylori-associated atrophic gastritis to gastric cancer.